Literature DB >> 19596835

Photodynamic effects of steroid-conjugated fluorophores on GABAA receptors.

Hong-Jin Shu1, Lawrence N Eisenman, Cunde Wang, Achintya K Bandyopadhyaya, Kathiresan Krishnan, Amanda Taylor, Ann M Benz, Brad Manion, Alex S Evers, Douglas F Covey, Charles F Zorumski, Steven Mennerick.   

Abstract

We have shown that fluorescent, 7-nitro-2,1,3-benzoxadiazol-4-yl amino (NBD)-conjugated neurosteroid analogs photopotentiate GABA(A) receptor function. These compounds seem to photosensitize a modification of receptor function, resulting in long-lived increases in responses to exogenous or synaptic GABA. Here we extend this work to examine the effectiveness of different fluorophore positions, conjugations, steroid structures, and fluorophores. Our results are generally in agreement with the idea that steroids with activity at GABA(A) receptors are the most potent photopotentiators. In particular, we find that an unnatural enantiomer of an effective photopotentiating steroid is relatively weak, excluding the idea that membrane solubility alone, which is identical for enantiomer pairs, is solely responsible for potent photopotentiation. Furthermore, there is a significant correlation between baseline GABA(A) receptor activity and photopotentiation. Curiously, both sulfated steroids, which bind a presumed external neurosteroid antagonist site, and hydroxysteroids, which bind an independent site, are effective. We also find that a rhodamine dye conjugated to a 5beta-reduced 3alpha-hydroxy steroid is a particularly potent and effective photopotentiator, with minimal baseline receptor activity up to 10 muM. Steroid conjugated fluorescein and Alexa Fluor 546 also supported photopotentiation, although the Alexa Fluor conjugate was weaker and required 10-fold higher concentration to achieve similar potentiation to the best NBD and rhodamine conjugates. Filling cells with steroid-conjugated or free fluorophores via whole-cell patch pipette did not support photopotentiation. FM1-43, another membrane-targeted, structurally unrelated fluorophore, also produced photopotentiation at micromolar concentrations. We conclude that further optimization of fluorophore and carrier could produce an effective, selective, light-sensitive GABA(A) receptor modulator.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19596835      PMCID: PMC2769041          DOI: 10.1124/mol.109.057687

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  32 in total

1.  Allosteric modulators affect the efficacy of partial agonists for recombinant GABA(A) receptors.

Authors:  G Maksay; S A Thompson; K A Wafford
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

2.  Positive allosteric modulation by ultraviolet irradiation on GABA(A), but not GABA(C), receptors expressed in Xenopus oocytes.

Authors:  Y Chang; Y Xie; D S Weiss
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

3.  Enhanced neurosteroid potentiation of ternary GABA(A) receptors containing the delta subunit.

Authors:  Kai M Wohlfarth; Matt T Bianchi; Robert L Macdonald
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

Review 4.  Recent developments in structure-activity relationships for steroid modulators of GABA(A) receptors.

Authors:  D F Covey; A S Evers; S Mennerick; C F Zorumski; R H Purdy
Journal:  Brain Res Brain Res Rev       Date:  2001-11

5.  A role for the redox site in the modulation of the NMDA receptor by light.

Authors:  Daniel Leszkiewicz; Elias Aizenman
Journal:  J Physiol       Date:  2002-12-01       Impact factor: 5.182

6.  Enantioselectivity of pregnanolone-induced gamma-aminobutyric acid(A) receptor modulation and anesthesia.

Authors:  D F Covey; D Nathan; M Kalkbrenner; K R Nilsson; Y Hu; C F Zorumski; A S Evers
Journal:  J Pharmacol Exp Ther       Date:  2000-06       Impact factor: 4.030

7.  3beta -hydroxypregnane steroids are pregnenolone sulfate-like GABA(A) receptor antagonists.

Authors:  Mingde Wang; Yejun He; Lawrence N Eisenman; Christopher Fields; Chun-Min Zeng; Jose Mathews; Ann Benz; Tao Fu; Erik Zorumski; Joe Henry Steinbach; Douglas F Covey; Charles F Zorumski; Steven Mennerick
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

Review 8.  Photodynamic therapy for cancer.

Authors:  Dennis E J G J Dolmans; Dai Fukumura; Rakesh K Jain
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

9.  NMDA potentiation by visible light in the presence of a fluorescent neurosteroid analogue.

Authors:  Lawrence N Eisenman; Hong-Jin Shu; Cunde Wang; Elias Aizenman; Douglas F Covey; Charles F Zorumski; Steven Mennerick
Journal:  J Physiol       Date:  2009-04-29       Impact factor: 5.182

10.  The influence of subunit composition on the interaction of neurosteroids with GABA(A) receptors.

Authors:  Delia Belelli; Anna Casula; Alice Ling; Jeremy J Lambert
Journal:  Neuropharmacology       Date:  2002-09       Impact factor: 5.250

View more
  2 in total

1.  Diverse voltage-sensitive dyes modulate GABAA receptor function.

Authors:  Steven Mennerick; Mariangela Chisari; Hong-Jin Shu; Amanda Taylor; Michael Vasek; Lawrence N Eisenman; Charles F Zorumski
Journal:  J Neurosci       Date:  2010-02-24       Impact factor: 6.167

2.  A clickable neurosteroid photolabel reveals selective Golgi compartmentalization with preferential impact on proximal inhibition.

Authors:  Xiaoping Jiang; Hong-Jin Shu; Kathiresan Krishnan; Mingxing Qian; Amanda A Taylor; Douglas F Covey; Charles F Zorumski; Steven Mennerick
Journal:  Neuropharmacology       Date:  2016-04-22       Impact factor: 5.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.